A Single Dose Pharmacokinetics Study of LY2624803 in Subjects With Hepatic Impairment

Trial Profile

A Single Dose Pharmacokinetics Study of LY2624803 in Subjects With Hepatic Impairment

Discontinued
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs LY 2624803 (Primary)
  • Indications Insomnia
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 02 Jun 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 14 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top